ES2099700T3 - Anilidas de acido 5-metil-isoxazol-4-carboxilico y anilidas de acido 2-hidroxietilidenciano para el tratamiento de enfermedades oculares. - Google Patents

Anilidas de acido 5-metil-isoxazol-4-carboxilico y anilidas de acido 2-hidroxietilidenciano para el tratamiento de enfermedades oculares.

Info

Publication number
ES2099700T3
ES2099700T3 ES90115691T ES90115691T ES2099700T3 ES 2099700 T3 ES2099700 T3 ES 2099700T3 ES 90115691 T ES90115691 T ES 90115691T ES 90115691 T ES90115691 T ES 90115691T ES 2099700 T3 ES2099700 T3 ES 2099700T3
Authority
ES
Spain
Prior art keywords
anilids
acid
methyl
hydroxyethylidencian
isoxazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90115691T
Other languages
English (en)
Inventor
Stella M Robertson
Laura Smith Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of ES2099700T3 publication Critical patent/ES2099700T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCUBRE EL USO DE ANILIDAS DE ACIDO 5-METILOISOXAZOL-4 RA TRATAR ENFERMEDADES OCULARES CON INMUNO ETIOLOGIA.
ES90115691T 1989-08-18 1990-08-16 Anilidas de acido 5-metil-isoxazol-4-carboxilico y anilidas de acido 2-hidroxietilidenciano para el tratamiento de enfermedades oculares. Expired - Lifetime ES2099700T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39586089A 1989-08-18 1989-08-18

Publications (1)

Publication Number Publication Date
ES2099700T3 true ES2099700T3 (es) 1997-06-01

Family

ID=23564835

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90115691T Expired - Lifetime ES2099700T3 (es) 1989-08-18 1990-08-16 Anilidas de acido 5-metil-isoxazol-4-carboxilico y anilidas de acido 2-hidroxietilidenciano para el tratamiento de enfermedades oculares.

Country Status (15)

Country Link
EP (1) EP0413329B1 (es)
JP (1) JP3131693B2 (es)
KR (1) KR100192745B1 (es)
AT (1) ATE148628T1 (es)
AU (1) AU633346B2 (es)
CA (1) CA2023560C (es)
DD (1) DD297328A5 (es)
DE (1) DE69029884T2 (es)
DK (1) DK0413329T3 (es)
ES (1) ES2099700T3 (es)
HU (1) HU215959B (es)
IE (1) IE902978A1 (es)
IL (1) IL95412A (es)
TW (1) TW287948B (es)
ZA (1) ZA906544B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538783B1 (de) * 1991-10-23 1995-09-27 Hoechst Aktiengesellschaft N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft
TW314467B (es) * 1993-03-31 1997-09-01 Hoechst Ag
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
CA2202904C (en) * 1994-10-17 2006-12-19 Yukio Amano Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
DE102006017896A1 (de) † 2006-04-13 2007-10-25 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Leflunomid enthaltende pharmazeutische Zusammensetzungen
SG11201608835VA (en) 2014-05-08 2016-11-29 Panoptes Pharma Ges M B H Compounds for treating ophthalmic diseases and disorders
WO2023182871A1 (ko) * 2022-03-25 2023-09-28 바스테라 주식회사 3-페닐이속사졸 유도체 및 이를 유효성분으로 함유하는 안질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES448386A1 (es) 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
HUT59600A (en) 1992-06-29
DE69029884D1 (de) 1997-03-20
JPH0390024A (ja) 1991-04-16
EP0413329A2 (en) 1991-02-20
DD297328A5 (de) 1992-01-09
KR910004193A (ko) 1991-03-28
IL95412A0 (en) 1991-06-30
AU633346B2 (en) 1993-01-28
JP3131693B2 (ja) 2001-02-05
IL95412A (en) 1996-01-31
TW287948B (es) 1996-10-11
DK0413329T3 (da) 1997-08-18
HU905064D0 (en) 1991-01-28
EP0413329B1 (en) 1997-02-05
AU6110490A (en) 1991-02-21
ZA906544B (en) 1991-06-26
DE69029884T2 (de) 1997-08-14
ATE148628T1 (de) 1997-02-15
EP0413329A3 (en) 1992-04-15
IE902978A1 (en) 1991-02-27
CA2023560C (en) 2000-12-12
HU215959B (hu) 1999-03-29
KR100192745B1 (ko) 1999-06-15
CA2023560A1 (en) 1991-02-19

Similar Documents

Publication Publication Date Title
ES2099700T3 (es) Anilidas de acido 5-metil-isoxazol-4-carboxilico y anilidas de acido 2-hidroxietilidenciano para el tratamiento de enfermedades oculares.
BR9007938A (pt) Metodo e aparelho o tratamento de glaucoma
NO911624L (no) Farmasoeytiske forbindelser.
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
ES2083396T3 (es) Acidos fenilalcan(en)oicos.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
NO912545D0 (no) Nye 3,3'-ditobis (propionsyrer) og estere derav samt fremgangsmaate for dens fremstilling.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
NO925048L (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
KR920700044A (ko) 눈의 동공수축을 유도 및 방지하기 위한 방법 및 수단
NO912528D0 (no) Behandling av sykdommer forbundet med jodmangel.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
BR6700414U (pt) Rebaixamento periferico de lentes oftalmicas divergentes e/ou negativas
FR2442052A1 (fr) Composition ophtalmique topique et methode d'utilisation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413329

Country of ref document: ES